<DOC>
	<DOC>NCT01173770</DOC>
	<brief_summary>This is a First-In-Man study designed to examine the safety, tolerability, pharmacokinetics and functional activity of ADC3680B after single and multiple doses in healthy male volunteers.</brief_summary>
	<brief_title>A Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ADC3680B in Healthy Volunteers</brief_title>
	<detailed_description />
	<criteria>Healthy male subjects between the ages of 18 and 55 years Body Mass Index (BMI) of 18 to 30 kg/m2 Signed and dated written informed consent prior to admission into the study Willing and able to comply with the requirements of the protocol and available to complete the study Evidence of history of any clinically significant medical disorder History of severe allergy/hypersensitivity or ongoing allergy/hypersensitivity</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>July 2010</verification_date>
</DOC>